<page><title>CAV3-related distal myopathy</title><url>https://medlineplus.gov/genetics/condition/cav3-related-distal-myopathy</url><content>CAV3-related distal myopathy
To use the sharing features on this page, please enable JavaScript.
Description
CAV3
-related distal myopathy is one form of distal myopathy, a group of disorders characterized by weakness and loss of function affecting the muscles farthest from the center of the body (distal muscles), such as those of the hands and feet. People with
CAV3
-related distal myopathy experience wasting (atrophy) and weakness of the small muscles in the hands and feet that generally become noticeable in adulthood. A bump or other sudden impact on the muscles, especially those in the forearms, may cause them to exhibit repetitive tensing (percussion-induced rapid contraction). The rapid contractions can continue for up to 30 seconds and may be painful. Overgrowth (hypertrophy) of the calf muscles can also occur in
CAV3
-related distal myopathy. The muscles closer to the center of the body (proximal muscles) such as the thighs and upper arms are normal in this condition.
Frequency
The prevalence of
CAV3
-related distal myopathy is unknown. Only a few affected individuals have been described in the medical literature.
Causes
CAV3
-related distal myopathy is part of a group of conditions called caveolinopathies, which are muscle disorders caused by mutations in the
CAV3
gene. The
CAV3
gene provides instructions for making a protein called caveolin-3, which is found in the membrane surrounding muscle cells. This protein is the main component of caveolae, which are small pouches in the muscle cell membrane. Within the caveolae, the caveolin-3 protein acts as a scaffold to organize other molecules that are important for cell signaling and maintenance of the cell structure.
CAV3
gene mutations result in a shortage of caveolin-3 protein in the muscle cell membrane and a reduction in the number of caveolae. Researchers suggest that a shortage of caveolae impairs the structural integrity of muscle cells, interferes with cell signaling, and causes the self-destruction of cells (apoptosis). The resulting degeneration of muscle tissue leads to the signs and symptoms of
CAV3
-related distal myopathy.
In addition to
CAV3
-related distal myopathy,
CAV3
gene mutations can cause other caveolinopathies including
limb-girdle muscular dystrophy
,
rippling muscle disease
,
isolated hyperCKemia
, and a heart disorder called hypertrophic cardiomyopathy. Several
CAV3
gene mutations have been found to cause different caveolinopathies in different individuals. It is unclear why a single
CAV3
gene mutation may cause different patterns of signs and symptoms, even within the same family.
Learn more about the gene associated with CAV3-related distal myopathy
CAV3
Inheritance
This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has
one parent
with
CAV3
-related distal myopathy or another caveolinopathy. Rare cases result from
new mutations
in the gene and occur in people with no history of caveolinopathies in their family.
Other Names for This Condition
Distal myopathy, Tateyama type
MPDT
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Distal myopathy, Tateyama type
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Catalog of Genes and Diseases from OMIM
MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT
Scientific Articles on PubMed
PubMed
References
Aboumousa A, Hoogendijk J, Charlton R, Barresi R, Herrmann R, Voit T, Hudson
J, Roberts M, Hilton-Jones D, Eagle M, Bushby K, Straub V. Caveolinopathy--new
mutations and additional symptoms. Neuromuscul Disord. 2008 Jul;18(7):572-8. doi:
10.1016/j.nmd.2008.05.003. Epub 2008 Jun 25.
Citation on PubMed
Gazzerro E, Bonetto A, Minetti C. Caveolinopathies: translational implications
of caveolin-3 in skeletal and cardiac muscle disorders. Handb Clin Neurol.
2011;101:135-42. doi: 10.1016/B978-0-08-045031-5.00010-4.
Citation on PubMed
Gazzerro E, Sotgia F, Bruno C, Lisanti MP, Minetti C. Caveolinopathies: from
the biology of caveolin-3 to human diseases. Eur J Hum Genet. 2010
Feb;18(2):137-45. doi: 10.1038/ejhg.2009.103. Epub 2009 Jul 8. Erratum In: Eur J
Hum Genet. 2009 Dec;17(12):1692.
Citation on PubMed
or
Free article on PubMed Central
Tateyama M, Aoki M, Nishino I, Hayashi YK, Sekiguchi S, Shiga Y, Takahashi T,
Onodera Y, Haginoya K, Kobayashi K, Iinuma K, Nonaka I, Arahata K, Itoyama Y.
Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy.
Neurology. 2002 Jan 22;58(2):323-5. doi: 10.1212/wnl.58.2.323. Erratum In:
Neurology 2002 Mar 12;58(5):839. Itoyoma Y [corrected to Itoyama Y].
Citation on PubMed
Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP. Caveolinopathies:
mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases.
Neurology. 2004 Feb 24;62(4):538-43. doi: 10.1212/wnl.62.4.538.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>